What Is: Enteric Nervous System: The Second Brain

Scientific Frontline: Extended "At a Glance" Summary: The Enteric Nervous System (ENS)

The Core Concept: The Enteric Nervous System (ENS) is a highly sophisticated, autonomous network of approximately 500 million neurons and supportive glial cells embedded within the human gastrointestinal tract. Often referred to as the body's "second brain," it operates independently of the central nervous system to govern digestion, mucosal immunity, and systemic physiological homeostasis.

Key Distinction/Mechanism: Unlike traditional peripheral nerves that passively relay brain commands, the ENS acts as an autonomous sensory-motor computing matrix. It detects local physical and chemical stimuli via Intrinsic Primary Afferent Neurons (IPANs), processes this data through complex interneuron circuits, and executes precise muscular and secretory reflexes using over 30 distinct neurotransmitters, including massive quantities of locally synthesized serotonin.

Major Frameworks/Components: 

• The Myenteric Plexus (Auerbach's Plexus): Located deep between the circular and longitudinal muscular layers of the gut, this network primarily orchestrates smooth muscle contraction and the rhythmic phenomena of the peristaltic reflex.
• The Submucosal Plexus (Meissner's Plexus): Situated in the submucosa near the gut lumen, this network regulates localized gastrointestinal secretion, mucosal blood flow, and the selective absorption of water and nutrients.
• Enteric Glial Cells (EGCs): Dynamic, non-neuronal support cells that heavily outnumber neurons. They are indispensable for maintaining the intestinal epithelial barrier, supporting the stem cell niche via WNT ligands, and actively coordinating mucosal immune responses.
• The Gut-Brain Axis (GBA): A bidirectional communication superhighway between the ENS and the central nervous system, primarily utilizing the vagus nerve—which functionally acts as a massive sensory conduit, sending 90% of its data upward to the brain.
• Braak's Hypothesis: A paradigm-shifting neurological framework suggesting that idiopathic Parkinson's disease physically originates in the ENS via misfolded alpha-synuclein proteins, which propagate in a prion-like manner retrogradely up the vagus nerve to the brain.

Enhancing gut-brain communication reversed cognitive decline, improved memory formation in aging mice

Stanford Medicine researchers have found a critical link between bacteria living in the gut and aging-related cognitive decline.
Image Credit: Scientific Frontline

Scientific Frontline: "At a Glance" Summary: Gut-Brain Cognitive Decline

• Main Discovery: Aging-associated alterations in the gut microbiome, notably the proliferation of the bacteria Parabacteroides goldsteinii, incite an inflammatory response that disrupts vagus nerve signaling to the hippocampus and directly drives cognitive decline.
• Methodology: Researchers conducted co-housing experiments to transfer microbiomes between young and old mice, utilized germ-free mouse models, administered broad-spectrum antibiotics, and employed vagus nerve stimulation while assessing spatial navigation and memory via maze and object recognition tests.
• Key Data: Young mice colonized with older microbiomes developed severe memory deficits, whereas older mice treated with vagus nerve stimulation or raised in germ-free environments maintained cognitive performance levels indistinguishable from two-month-old animals.
• Significance: The timeline of age-related memory loss is not an immutable, brain-intrinsic process, but rather a flexible mechanism actively regulated by gastrointestinal microbiome composition and peripheral immune activity.
• Future Application: Clinicians may eventually utilize oral modulation of gut metabolites or non-invasive peripheral neuron interventions, such as vagus nerve stimulation, to prevent or reverse cognitive decline in aging human populations.
• Branch of Science: Pathology, Neurology, Geriatrics, Microbiology, and Gastroenterology.
• Additional Detail: The cognitive deterioration pathway is specifically mediated by medium-chain fatty acid metabolites that trigger gut-dwelling myeloid cells to initiate the vagus-inhibiting inflammation.

Altered gut bacteria may be early sign of Alzheimer’s disease

 

Alzheimer’s disease causes changes to the brain that begin two decades or more before symptoms appear. A study by researchers at Washington University School of Medicine in St. Louis reveals that the bacteria that live in the gut also change before Alzheimer’s symptoms arise, a discovery that could lead to diagnostics or treatments for Alzheimer’s disease that target the gut microbiome.
Image Credit: Gerd Altmann

People in the earliest stage of Alzheimer’s disease — after brain changes have begun but before cognitive symptoms become apparent — harbor an assortment of bacteria in their intestines that differs from the gut bacteria of healthy people, according to a study by researchers at Washington University School of Medicine in St. Louis.

The findings, published June 14 in Science Translational Medicine, open up the possibility of analyzing the gut bacterial community to identify people at higher risk of developing dementia, and of designing microbiome-altering preventive treatments to stave off cognitive decline.

“We don’t yet know whether the gut is influencing the brain or the brain is influencing the gut, but this association is valuable to know in either case,” said co-corresponding author Gautam Dantas, PhD, the Conan Professor of Laboratory and Genomic Medicine. “It could be that the changes in the gut microbiome are just a readout of pathological changes in the brain. The other alternative is that the gut microbiome is contributing to Alzheimer’s disease, in which case altering the gut microbiome with probiotics or fecal transfers might help change the course of the disease.”

Brain-Belly Connection: Gut Health May Influence Likelihood of Developing Alzheimer’s

UNLV study pinpoints 10 bacterial groups associated with Alzheimer’s disease, provides new insights into the relationship between gut makeup and dementia.
Illustration Credit: Julien Tromeur

Could changing your diet play a role in slowing or even preventing the development of dementia? We’re one step closer to finding out, thanks to a new UNLV study that bolsters the long-suspected link between gut health and Alzheimer’s disease.

The analysis — led by a team of researchers with the Nevada Institute of Personalized Medicine (NIPM) at UNLV and published this spring in the Nature journal Scientific Reports — examined data from dozens of past studies into the belly-brain connection. The results? There’s a strong link between particular kinds of gut bacteria and Alzheimer’s disease.

Between 500 and 1,000 species of bacteria exist in the human gut at any one time, and the amount and diversity of these microorganisms can be influenced by genetics and diet.

The UNLV team’s analysis found a significant correlation between 10 specific types of gut bacteria and the likelihood of developing Alzheimer’s disease. Six categories of bacteria — Adlercreutzia, Eubacterium nodatum group, Eisenbergiella, Eubacterium fissicatena group, Gordonibacter, and Prevotella9 — were identified as protective, and four types of bacteria — Collinsella, Bacteroides, Lachnospira, and Veillonella — were identified as a risk factor for Alzheimer’s disease.

Progesterone could protect against Parkinson's

Lennart Stegemann (left) and Paula Neufeld are working on their doctoral theses and were able to celebrate an early success with the top-class publication.
Photo Credit: © RUB, Marquard

Scientific Frontline: Extended "At a Glance" Summary: Progesterone's Neuroprotective Role in Parkinson's Disease

The Core Concept: Progesterone, a natural steroid hormone, exhibits neuroprotective properties that preserve the viability of nerve cells within the gastrointestinal tract under toxic stress.

Key Distinction/Mechanism: Rather than acting exclusively on the central nervous system, progesterone binds to newly identified receptors in the enteric nervous system (ENS). This localized protection prevents cellular death in the gut, which may interrupt the progression of neurodegenerative signaling to the brain via the gut-brain axis.

Major Frameworks/Components:

• The Enteric Nervous System (ENS): A sophisticated network of approximately 100 million nerve cells autonomously governing the gastrointestinal tract, frequently termed the "second brain."
• The Gut-Brain Axis: A bidirectional communication network connecting the ENS and the central nervous system (CNS), heavily influenced by the intestinal microbiome and the vagus nerve.
• Neurodegeneration Simulation: An experimental model utilizing cellular toxins on ENS cultures to replicate the localized cellular damage characteristic of Parkinson's disease.

Your gut senses the difference between real sugar and artificial sweetener

A section of mouse intestines shows in green the relatively scarce neuropod cells in the epithelium that are responsible for communicating conditions inside the gut to the nervous system outside. 
Credit: Borhoquez Lab, Duke

Your taste buds may or may not be able to tell real sugar from a sugar substitute like Splenda, but there are cells in your intestines that can and do distinguish between the two sweet solutions. And they can communicate the difference to your brain in milliseconds.

Not long after the sweet taste receptor was identified in the mouths of mice 20 years ago, scientists attempted to knock those taste buds out. But they were surprised to find that mice could still somehow discern and prefer natural sugar to artificial sweetener, even without a sense of taste.

The answer to this riddle lies much further down in the digestive tract, at the upper end of the gut just after the stomach, according to research led by Diego Bohórquez, an associate professor of medicine and neurobiology in the Duke University School of Medicine.

In a paper appearing Jan. 13 in Nature Neuroscience, “we’ve identified the cells that make us eat sugar, and they are in the gut,” Bohórquez said. Infusing sugar directly into the lower intestine or colon does not have the same effect. The sensing cells are in the upper reaches of the gut, he said.

Messengers from gut to brain

 

Thomas Korn is a professor for Experimental Neuroimmunology at TUM.
Image: Magdalena Jooss / TUM

Scientists have long been aware of a link between the gut microbiome and the central nervous system (CNS). Until now, however, the immune cells that move from the gut into the CNS and thus the brain had not been identified. A team of researchers in Munich has now succeeded in using violet light to make these migrating T cells visible for the first time. This opens up avenues for developing new treatment options for diseases such as multiple sclerosis (MS) and cancer.

The link between the gut microbiome and the CNS, known as the gut/brain axis (GBA), is believed to be responsible for many things: a person’s body weight, autoimmune diseases, depression, mental illnesses and Alzheimer’s disease. Researchers at the Technical University of Munich (TUM) and LMU University Hospital Munich have now succeeded in making this connection visible for the first time. This is cause for hope – for those suffering from MS, for example. It may offer ways to adapt treatments, and T cells could perhaps be modified before reaching the brain.

The immune system is affected by environmental factors – also in the central nervous system in case of MS patients. This autoimmune disease is subject to repeated flare-ups, experienced by patients as the improvement or worsening of their condition. T cells collect information and, in MS patients, carry it to the central nervous system (in the brain or spinal cord) where an immune response is triggered. Until now, however, it was long uncertain how and from where the T cells were traveling to the CNS.

The team working with Thomas Korn, a professor of experimental neuroimmunology at TUM, has developed a method for marking immune cells in mice using photoconvertible proteins. The T cells can then be made visible with violet light. The researchers successfully tested this method with the mouse model in lymph nodes, both in the gut and the skin. They were able to track the movement of the T cells from those locations into the central nervous systems.

T cells from the skin migrated into the gray and white matter of the CNS, while almost all T cells from the gut ended up in the white matter. For T cells in the brain, it was still possible to determine their origin. “What makes these insights so important is that they demonstrate for the first time that environmental influences impact the T cells in lymph nodes in the gut and the skin, which then carry this information into the distant organs,” says Prof. Thomas Korn. “The characteristics of the T cells are sufficiently stable for us to determine whether immune responses are influenced by skin or gut T cells,” adds LMU researcher Dr. Eduardo Beltrán, who performed the bioinformatic analyses in this study.

An important insight for MS patients: “If gut or skin cells were known to be the cause, the T cells could be treated at the source of the disease and predictions could be made on the progress of the chronic inflammation and autoimmune condition,” says first author Michael Hiltensperger. The results of the study could also mean a breakthrough for research on other autoimmune diseases or cancer.

Paper released in publication Nature Immunology

Source/Credit: Technical University of Munich

bio090621_01

What Is: The Human Microbiome

The Human Microbiome
Image Credit: Scientific Frontline stock image

The Invisible Organ

The human body is not a sterile, solitary entity. It is a dense, complex, and dynamic ecosystem. Each individual serves as a host to a vast community of microorganisms, collectively known as the human microbiota. This community, which resides in and on the body, is estimated to comprise between 10 trillion and 100 trillion symbiotic microbial cells. Early estimates, which have become a cornerstone of the field, suggested these microbial cells outnumber human cells by a ratio of ten to one. While more recent analyses propose a ratio closer to 1:1, the sheer scale of this microbial colonization remains staggering. These microbial cells, though only one-tenth to one-hundredth the size of a human cell, may account for up to five pounds of an adult's body weight.

This vast microbial community is not a passive passenger. It functions as a "virtual organ" of the body, or more precisely, a "metabolic organ". It is so deeply integrated into our physiology that we are dependent on it for essential life functions, including digestion, immune system development, and the production of critical nutrients.

Changes in gut microbiota influence which patients get AIG-related neuroendocrine tumors

Researchers took biopsies of AIG patients with and without neuroendocrine tumor growth to understand their bacterial communities
Image Credit: Osaka Metropolitan University

Researchers from Osaka Metropolitan University have discovered how the balance of bacteria in the stomach affects the growth of neuroendocrine tumors (NETs). By identifying the specific bacteria involved and the biochemical reactions that cause tumor growth, the researchers hope to create a new diagnostic technique to detect which patients are most likely to develop cancer.

Autoimmune gastritis (AIG) is a long-term condition in which the body’s immune system mistakenly attacks the lining of the stomach. This ongoing immune response gradually damages the stomach, affecting how it functions and its ability to protect itself from harmful agents. Over time, these changes can increase the risk of developing NETs, a type of tumor that develops from hormone-producing cells in the stomach.

Drawing a Line from the Gut Microbiome to Inflammation and Depression

Morganella morganii bacteria on a plate.
Photo Credit: Ajay Kumar Chaurasiya
(CC BY-SA 4.0)

It’s become increasingly clear that the gut microbiome can affect human health, including mental health. Which bacterial species influence the development of disease and how they do so, however, is only just starting to be unraveled.

For instance, some studies have found compelling links between one species of gut bacteria, Morganella morganii, and major depressive disorder. But until now no one could tell whether this bacterium somehow helps drive the disorder, the disorder alters the microbiome, or something else is at play.

Harvard Medical School researchers have now pinpointed a biologic mechanism that strengthens the evidence that M. morganii influences brain health and provides a plausible explanation for how it does so.

The findings, published in the Journal of the American Chemical Society, implicate an inflammation-stimulating molecule and offer a new target that could be useful for diagnosing or treating certain cases of the disorder. They also provide a roadmap for probing how other members of the gut microbiome influence human health and behavior.

“There is a story out there linking the gut microbiome with depression, and this study takes it one step further, toward a real understanding of the molecular mechanisms behind the link,” said senior author Jon Clardy, the Christopher T. Walsh, PhD Professor of Biological Chemistry and Molecular Pharmacology in the Blavatnik Institute at HMS.

Scientists rebuild microscopic circadian clock to control genes

Image Credit: Scientific Frontline

Scientific Frontline: "At a Glance" Summary

• Main Discovery: Researchers reproduced the simplest natural circadian system found in blue-green algae (cyanobacteria) within a test tube, demonstrating how a single clock signal coordinates daily gene switching.
• Methodology: The team utilized biochemical, structural, and in vivo methods to recreate the rhythmic genetic switching process in vitro, observing how the mechanism turns off "morning" genes while simultaneously activating "evening" genes.
• Key Data: The study successfully modeled the "antiphase" gene expression where cellular processes peak distinctly at dusk and dawn, orchestrated by a simplified clocking mechanism relative to complex organisms.
• Significance: This research elucidates the fundamental molecular mechanisms by which circadian clocks regulate gene activity, revealing how immense cellular complexity is managed by a simple rhythmic system.
• Future Application: Findings may enable the development of scheduling tools for the timed biosynthesis of valuable compounds in biotechnology and offer new strategies for regulating human gut microbiota to support overall health.
• Branch of Science: Molecular Biology, Chronobiology, and Biotechnology
• Additional Detail: The study, published in Nature Structural and Molecular Biology, highlights the potential connection between unstable circadian rhythms and mental health issues, as well as the optimization of medicine administration timing.

What Is: Biological Plasticity

Image Credit: Scientific Frontline

The Paradigm of the Reactive Genome 

The history of biological thought has long been dominated by a tension between the deterministic rigidity of the genotype and the fluid adaptability of the phenotype. For much of the 20th century, the Modern Synthesis emphasized the primacy of genetic mutation and natural selection, often relegating environmental influence to a mere background filter against which genes were selected. In this view, the organism was a fixed readout of a genetic program, stable and unwavering until a random mutation altered the code. However, a profound paradigm shift has occurred, repositioning the organism not as a static entity but as a dynamic system capable of producing distinct, often dramatically different phenotypes from a single genotype in response to environmental variation. This capacity, known as biological or phenotypic plasticity, is now recognized as a fundamental property of life, permeating every level of biological organization—from the epigenetic modification of chromatin in a stem cell nucleus to the behavioral phase transitions of swarming locusts, and ultimately to the structural rewiring of the mammalian cortex following injury.